HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Immunogenetic aspects of early rheumatoid arthritis].

Abstract
The study is aimed to investigate the distribution of alleles of HLA-DRB1 gene in patients with early rheumatoid arthritis and healthy individuals in Russian population, and evaluate their significance as molecular genetic markers of rheumatoid arthritis predisposition and protection. The association between alleles of HLA-DRB1 genes, antibodies to cyclic citrullinated peptides and IgM rheumatoid factor was also studied. Low and high resolution HLA-DRB1 genotyping were compared. In the cohort of patients with early rheumatoid arthritis, the alleles of HLA-DRB1 gene were found to be markers of rheumatoid arthritis protection/risk, especially in the homozygous state. They determined production of antibodies to cyclic citrullinated peptides but were not associated with rheumatoid factor IgM levels. These findings support different autoimmune mechanisms of rheumatoid arthritis pathogenesis.
AuthorsI A Guseva, N V Demidova, N E Soroka, A A Novikov, E L Luchikhina, E N Aleksandrova, G V Lukina, E V Fedorenko, E S Aronova, E Iu Samarkina, M N Boldyreva, D Iu Trofimov, D E Karateev, E L Nasonov
JournalVestnik Rossiiskoi akademii meditsinskikh nauk (Vestn Ross Akad Med Nauk) Issue 4 Pg. 36-43 ( 2013) ISSN: 0869-6047 [Print] Russia (Federation)
PMID24003720 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Autoantibodies
  • Biomarkers
Topics
  • Adolescent
  • Adult
  • Aged
  • Autoantibodies (genetics, immunology)
  • Biomarkers (analysis)
  • Female
  • Follow-Up Studies
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Immunogenetics (methods)
  • Male
  • Middle Aged
  • Rheumatic Fever (genetics, immunology)
  • Time Factors
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: